Evidence map›Paper›PMID 24836739›Full record

SynthesisCNS neuroscience & therapeutics2014

Systematic review of clinical trials assessing pharmacological properties of Salvia species on memory, cognitive impairment and Alzheimer's disease.

Marco Miroddi, Michele Navarra, Maria C Quattropani, Fabrizio Calapai, Sebastiano Gangemi, Gioacchino Calapai

Abstract readSystematic Review
In one paragraph

Synthesis in CNS neuroscience & therapeutics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. American Basil,Nutrients · 2025
    Article
  5. Article
  6. Hydroethanolic Extract ofTheScientificWorldJournal · 2025
    Article
  7. Review
  8. Article
  9. Enhancement of the Antibiofilm Activity of Nisin againstPathogens (Basel, Switzerland) · 2023
    Article
  10. A Focused Review on Cognitive Improvement by the GenusPharmaceuticals (Basel, Switzerland) · 2023
    Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Supercritical Antisolvent Fractionation of Antioxidant Compounds fromInternational journal of molecular sciences · 2021
    Article
  18. Acute Effects ofFrontiers in nutrition · 2021
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Marco MiroddiDepartment of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
Michele Navarra
Maria C Quattropani
Fabrizio Calapai
Sebastiano Gangemi
Gioacchino Calapai

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Salvia officinalis L. and Salvia lavandulaefolia L. have a longstanding use as traditional herbal remedies that can enhance memory and improve cognitive functions. Pharmacological actions of S. officinalis and S. lavandulaefolia on healthy subjects and on patients suffering of cognitive decline have been investigated. Aim of this review was to summarize published clinical trials assessing effectiveness and safety of S. officinalis and S. lavandulaefolia in the enhancement of cognitive performance in healthy subjects and neurodegenerative illnesses. Furthermore, to purchase a more complete view on safety of S. officinalis and S. lavandulaefolia, we collected and discussed articles regarding toxicity and adverse reactions. Eight clinical studies investigating on acute effects of S. officinalis on healthy subjects were included in the review. Six studies investigated on the effects of S. officinalis and S. lavandaeluaefolia on cognitive performance in healthy subjects. The two remaining were carried out to study the effects of sage on Azheimer's disease. Our review shows that S. officinalis and S. lavandulaefolia exert beneficial effects by enhancing cognitive performance both in healthy subjects and patients with dementia or cognitive impairment and is safe for this indication. Unfortunately, promising beneficial effects are debased by methodological issues, use of different herbal preparations (extracts, essential oil, use of raw material), lack of details on herbal products used. We believe that sage promising effects need further higher methodological standard clinical trials.

Indexed as

Alzheimer DiseaseClinical Trials as TopicCognition DisordersHumansMemoryPhytotherapyPlant PreparationsSalviaPlant PreparationsAlzheimer's diseaseCognitive impairmentMemorySalvia lavandulaefoliaSalvia officinalis

Identifiers

PMID24836739
PMCPMC6493168

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.